UNSPSC 51191545: Epithiazide or epitizide

This classification denotes a thiazide diuretic with the molecular formula C10H11ClF3N3O4S3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5B266B85J1, chemically known as 6-chloro-3, 4-dihydro-7-sulfamoyl-3-(2,2,2-trifluoroethylthiomethyl)-2h-1,2, 4-benzothiadiazine 1,1-dioxide but generally known as epithiazide, which bears US NIH Compound Identifier 15671. European Medicines Agency schedules Epitizide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06573MIG.

The term EPITIZIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). Epithiazide or epitizide bears US NLM identifiers UMLS ID C2700005 and NCI Concept Code C77141. SMILES: C1=C2C(=CC(=C1CL)S(=O)(=O)N)S(=O)(=O)NC(N2)CSCC(F)(F)F.

UNSPSC 51191545 Epithiazide or epitizide is a Commodity code that maps to chemical and pharmaceutical supply procurement by state and local government entities, though recent opportunities show limited direct activity under this specific code designation. The solicitations posted indicate that state and local buyers use this code family for water treatment chemicals and generic pharmaceutical products supplied through cooperative purchasing agreements, where the actual commodities span sodium bisulfite for municipal water pollution control facilities and multi-source generic pharmaceuticals and OTC products for distributed government healthcare operations. Issuing bodies include municipal governments—represented by the City of Meriden, Connecticut—and state-level cooperative purchasing alliances administering multi-jurisdictional procurement on behalf of member agencies and local government facilities across multiple states.

Activity appears concentrated in the Upper Midwest and Northeast. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP on January 20, 2026 to establish multiple contracts for generic multi-source pharmaceuticals and OTC products, with proposals due March 26, 2026 and awarded vendors to be provided to authorized wholesalers by May 15, 2026; the resulting agreements are effective July 1, 2026 with a two-year initial term. The City of Meriden, Connecticut posted an IFB on July 8, 2026 for sodium bisulfite chemical supply to its Water Pollution Control Facility, with bids due July 29, 2026, evaluating pricing on a unit-cost basis and requiring performance and labor-and-material payment bonds. Both opportunities reflect state and local demand for supply-chain managed commodities through established vendor networks and wholesaler relationships, with emphasis on cGMP compliance, FDA requirements, and insurance thresholds ranging from $2 million to $5 million per occurrence depending on the commodity class.